Katie Coleman: Three years since my last cancer-related intervention
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation, shared a post on X:
“Today marks exactly three years since we ablated the final tumors from my liver, my last cancer-related intervention.
I’ve found myself speechless trying to describe how surreal of a feeling that has been today at IKCSNA24.
Gratitude doesn’t even begin to scratch the surface.”
More posts featuring Katie Coleman.
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products.
As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research. Katie combines her technical expertise and unique perspective to develop products that improve patient outcomes and support the foundation’s mission.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023